TalkPoint and Life Technologies partner for webinar event to discuss a major advancement in transient expression technology

Share Article

“Discover the Expi293™ Expression System” will detail how to produce more protein, while using lower culture volume, in rapid time

News Image
By partnering with TalkPoint to introduce this revolutionary new system, we are able to strengthen the Expi293™launch by sharing this valuable content with more of the research community.

TalkPoint, the leader in global communications technology, specializing in browser-based audio and video webcasting, and Life Technologies, a global biotechnology company dedicated to improving the human condition, are partnering to deliver the webcasting event titled “Discover the Expi293™ Expression System.”

The complimentary TalkPoint powered webinar will detail how the Expi293™ Expression System produces a higher-density culture for maximum protein yield in a transient mammalian system. Participants will have two opportunities to join the discussion on Wednesday, November 7, and they can attend the webinar at 6:00 a.m. PT/9:00 a.m. ET or 10:00 a.m. PT/1:00 p.m. ET.

Henry Chiou, senior product development manager at Life Technologies, will share his industry insight in this webinar presentation showcasing the ease-of use, robustness and scalability of the Expi293™ Expression System.

Additional benefits of the Expi293™System covered during the webcast include:

  •     Higher transfection efficiency
  •     3-10X greater protein yield
  •     Improved cell viability
  •     Smaller culture volumes

Interested attendees may register for the webinar by clicking here.

“TalkPoint is happy to partner with Life Technologies to showcase this major breakthrough in scientific technology,” said Nick Balletta, CEO of TalkPoint. “By providing the platform for this event, we hope to provide an interactive discussion and share the efficiencies of this new system with a larger audience.”

“By partnering with TalkPoint to introduce this revolutionary new system, we are able to strengthen the Expi293™launch by sharing this valuable content with more of the research community,” said Sahil Nock, global market development manager, Life Technologies. “After extensive beta testing with 22 external sites worldwide and documenting a 4.6x average increase in yield for all proteins, we are excited to help webinar attendees obtain these successful protein production results for themselves.”

For more information on the Expi293™ Expression System, please visit http://www.lifetechnologies.com/expi293

About TalkPoint

TalkPoint is the industry leader in global communications technology, specializing in browser-based audio and video webcasting. Since 1998, TalkPoint's easy-to-use, Software-as-a-Service (SaaS) cloud platform has facilitated more than 20,000 live webcasting events per year for the top Fortune 500 and FTSE 100 companies. From investor relations and corporate communications to product launches and continuing education, TalkPoint offers scalable and flexible technology to meet today's business communication needs. For more information, visit http://www.talkpoint.com.    

About Life Technologies

Life Technologies Corporation is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes and TaqMan products. Life Technologies had sales of $3.6 billion in 2010, has a workforce of approximately 11,000 people, has a presence in approximately 160 countries, and possesses one of the largest intellectual property estates in the life sciences industry, with approximately 3,900 patents and exclusive licenses. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lindsay Rolfson
Visit website